Position in TEVA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$10,026,948
-$1,102,538 QoQ
Shares Held
332,900
-6.6% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GABELLI FUNDS LLC holds $36,352,371 across 10 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (27.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
332,900 | $10,026,948 | |
| 2 | PRGO |
PERRIGO Co plc
|
893,359 | $9,594,675 | |
| 3 | ZTS |
Zoetis Inc.
|
60,450 | $7,145,794 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
134,250 | $3,212,602 | |
| 5 | VTRS |
Viatris Inc
|
213,200 | $2,880,332 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
24,000 | $1,820,400 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
23,000 | $1,188,870 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
56,000 | $302,400 |
All Filings in TEVA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,026,948 | 332,900 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $11,129,486 | 356,600 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $8,921,835 | 441,675 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,399,121 | 441,475 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,687,102 | 435,075 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,099,700 | 367,500 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,324,690 | 184,500 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $812,500 | 50,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $451,520 | 32,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $334,080 | 32,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $326,400 | 32,000 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $310,236 | 41,200 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $373,470 | 42,200 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $392,160 | 43,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $435,780 | 54,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $428,640 | 57,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $554,010 | 59,000 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $472,590 | 59,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $613,620 | 63,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $683,298 | 69,020 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $831,110 | 72,020 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||